Incorporating Long-acting CABENUVA into Clinical Practice

Through an interactive format, expert faculty will present data from CUSTOMIZE, a hybrid phase III implementation-effectiveness study of long-acting cabotegravir and rilpivirine, and share practice-specific learnings to inform clinic set up. The panel discussion and Q&A session will give an opportunity for faculty to share learnings from their practical experience, and address questions around clinic set up along the entire HCP journey.

The ABCs of Long-acting CAB + RPV

The ABCs of Long-acting CAB + RPV

The ABCs of Long-acting CAB + RPV

ViiVHealthcare US

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Connect With Our Medical Experts

Find My ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Talk to a Medical Expert

Connect now with a live ViiV Medical Expert.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1‑888‑226‑8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or